These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 17234763

  • 1. Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor.
    Dolloff NG, Russell MR, Loizos N, Fatatis A.
    Cancer Res; 2007 Jan 15; 67(2):555-62. PubMed ID: 17234763
    [Abstract] [Full Text] [Related]

  • 2. Implication of platelet-derived growth factor receptor alpha in prostate cancer skeletal metastasis.
    Liu Q, Jernigan D, Zhang Y, Fatatis A.
    Chin J Cancer; 2011 Sep 15; 30(9):612-9. PubMed ID: 21880182
    [Abstract] [Full Text] [Related]

  • 3. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection.
    Soroceanu L, Akhavan A, Cobbs CS.
    Nature; 2008 Sep 18; 455(7211):391-5. PubMed ID: 18701889
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor.
    Dolloff NG, Shulby SS, Nelson AV, Stearns ME, Johannes GJ, Thomas JD, Meucci O, Fatatis A.
    Oncogene; 2005 Oct 13; 24(45):6848-54. PubMed ID: 16007172
    [Abstract] [Full Text] [Related]

  • 6. Targeting the {alpha} receptor for platelet-derived growth factor as a primary or combination therapy in a preclinical model of prostate cancer skeletal metastasis.
    Russell MR, Liu Q, Fatatis A.
    Clin Cancer Res; 2010 Oct 15; 16(20):5002-10. PubMed ID: 20813817
    [Abstract] [Full Text] [Related]

  • 7. Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.
    Loizos N, Xu Y, Huber J, Liu M, Lu D, Finnerty B, Rolser R, Malikzay A, Persaud A, Corcoran E, Deevi DS, Balderes P, Bassi R, Jimenez X, Joynes CJ, Mangalampalli VR, Steiner P, Tonra JR, Wu Y, Pereira DS, Zhu Z, Ludwig DL, Hicklin DJ, Bohlen P, Witte L, Kussie P.
    Mol Cancer Ther; 2005 Mar 15; 4(3):369-79. PubMed ID: 15767546
    [Abstract] [Full Text] [Related]

  • 8. Platelet-derived growth factor (PDGF) receptor-alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta -induced phenotypic transformation.
    Yu J, Deuel TF, Kim HR.
    J Biol Chem; 2000 Jun 23; 275(25):19076-82. PubMed ID: 10777515
    [Abstract] [Full Text] [Related]

  • 9. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
    Uren A, Merchant MS, Sun CJ, Vitolo MI, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C, Toretsky JA.
    Oncogene; 2003 Apr 17; 22(15):2334-42. PubMed ID: 12700668
    [Abstract] [Full Text] [Related]

  • 10. Sennoside B inhibits PDGF receptor signaling and cell proliferation induced by PDGF-BB in human osteosarcoma cells.
    Chen YC, Chang CN, Hsu HC, Chiou SJ, Lee LT, Hseu TH.
    Life Sci; 2009 Jun 19; 84(25-26):915-22. PubMed ID: 19393247
    [Abstract] [Full Text] [Related]

  • 11. The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms.
    Russell MR, Liu Q, Lei H, Kazlauskas A, Fatatis A.
    Cancer Res; 2010 May 15; 70(10):4195-203. PubMed ID: 20442296
    [Abstract] [Full Text] [Related]

  • 12. Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.
    Najy AJ, Won JJ, Movilla LS, Kim HR.
    Mol Cancer Res; 2012 Aug 15; 10(8):1087-97. PubMed ID: 22689130
    [Abstract] [Full Text] [Related]

  • 13. c-Src-dependent transactivation of PDGFR contributes to TNF-α-induced MMP-9 expression and functional impairment in osteoblasts.
    Tsai CL, Chen WC, Lee IT, Chi PL, Cheng SE, Yang CM.
    Bone; 2014 Mar 15; 60():186-97. PubMed ID: 24361597
    [Abstract] [Full Text] [Related]

  • 14. PDGF-D signaling in portal myofibroblasts and hepatic stellate cells proves identical to PDGF-B via both PDGF receptor type α and β.
    Borkham-Kamphorst E, Meurer SK, Van de Leur E, Haas U, Tihaa L, Weiskirchen R.
    Cell Signal; 2015 Jul 15; 27(7):1305-14. PubMed ID: 25819339
    [Abstract] [Full Text] [Related]

  • 15. Platelet-derived growth factor (PDGF) receptor-alpha-activated c-Jun NH2-terminal kinase-1 is critical for PDGF-induced p21WAF1/CIP1 promoter activity independent of p53.
    Yu J, Liu XW, Kim HR.
    J Biol Chem; 2003 Dec 05; 278(49):49582-8. PubMed ID: 14506245
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells.
    Russell MR, Jamieson WL, Dolloff NG, Fatatis A.
    Oncogene; 2009 Jan 22; 28(3):412-21. PubMed ID: 18850002
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, Frangogiannis NG.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2315-23. PubMed ID: 17161265
    [Abstract] [Full Text] [Related]

  • 20. Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses.
    Rolny C, Spillmann D, Lindahl U, Claesson-Welsh L.
    J Biol Chem; 2002 May 31; 277(22):19315-21. PubMed ID: 11912193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.